Genome editing coming of age for hemoglobinopathy
Mol Ther
.
2023 Mar 1;31(3):601-602.
doi: 10.1016/j.ymthe.2023.02.007.
Epub 2023 Feb 16.
Author
Haiyan Jiang
1
Affiliation
1
PointLoma BioSciences, 4401 Eastgate Mall, San Diego, CA 92121, USA. Electronic address: haiyan.jiang@pointlomabio.com.
PMID:
36803951
PMCID:
PMC10014269
DOI:
10.1016/j.ymthe.2023.02.007
No abstract available
Publication types
Editorial
MeSH terms
CRISPR-Cas Systems
Gene Editing*
Hemoglobinopathies* / genetics
Hemoglobinopathies* / therapy
Humans